Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Clearpoint Neuro Inc (NQ: CLPT )

11.25 +0.22 (+1.99%)
Streaming Delayed Price Updated: 3:35 PM EDT, Aug 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Clearpoint Neuro Inc

< Previous 1 2 3 Next >
CLPT Stock Earnings: ClearPoint Neuro Beats EPS, Beats Revenue for Q2 2024
CLPT stock results show that ClearPoint Neuro beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
The 3 Best Brain-Computer Interface Stocks to Buy Now
With the number of U.S. citizens aged 65 and above growing to 55.8 million, we could see brain-computer interface stocks accelerate. 
Via InvestorPlace
7 Growth Stocks That Could 5X in 5 Years
These top growth stocks across various sectors have the potential to deliver 5X returns in just five years. 
Via InvestorPlace
CLPT Stock Earnings: ClearPoint Neuro Beats EPS, Beats Revenue for Q1 2024
CLPT stock results show that ClearPoint Neuro beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
7 Penny Stocks That Could Make You a Fortune (If You Dare)
These penny stocks offer robust operational opportunities amid wider economic and market concerns pushing weaker companies downward. 
Via InvestorPlace
ClearPoint Neuro: Q4 Earnings Insights
Via Benzinga
Earnings Outlook For ClearPoint Neuro
Via Benzinga
ClearPoint Neuro: Q3 Earnings Insights
Via Benzinga
ClearPoint Neuro: Q1 Earnings Insights
Via Benzinga
The 3 Most Promising MedTech Stocks to Invest In Now
MedTech stocks are often overlooked despite the inherent healthcare growth trajectory and industry-wide innovative spirit. 
Via InvestorPlace
Earnings Scheduled For March 12, 2024
Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter. 
Via Benzinga
Earnings Scheduled For March 1, 2023
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million. 
Via Benzinga
The Top 7 Under-$15 Stocks to Buy in March 2024
These under-$15 stocks to buy are one of the few deals remaining in today's economic environment. Don't miss out. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Tech Trailblazers: 7 Small-Cap Stocks on the Verge of a Breakthrough
These small-cap tech stocks are well on their way to a meteoric and historic rise, but it isn't too late to jump on the bandwagon. 
Via InvestorPlace
The 3 Up-and-Coming Stocks That Could Make Your February Unforgettable
Finding an up-and-coming stock worth investing in is harder than it used to be, but you don't have to look far if you check out this list. 
Via InvestorPlace
The Next Johnson & Johnson? 3 Healthcare Stocks That Investors Shouldn’t Ignore.
Looking for the next generational winner in healthcare stocks? These are three of the top prospects today. 
Via InvestorPlace
3 Strong Buy Healthcare Stocks to Add to Your February Must-Watch List
These strong buy healthcare stocks are among analysts' favorite picks, and their strong market position tells us why. 
Via InvestorPlace
3 Small-Cap Healthcare Stocks to Buy and Hold Forever: January 2024
Small-cap healthcare stocks combine relative cheapness with advanced innovations including AI, automation, and more. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
7 Small-Cap Stocks With Huge Potential Flying Under the Radar
Small-cap stocks are massively undervalued and represent a unique investment opportunity for traders in 2024. 
Via InvestorPlace
7 Solid Small-Caps for 2024 and Beyond
Small-cap stocks are positioned to beat the biggest companies in 2024 as risk tolerance climbs and shares remain undervalued 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
Via Benzinga
Top 5 Health Care Stocks That Are Set To Fly In Q2
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  Friday's session saw 59 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  Monday's session saw 41 companies set new 52-week lows. 
Via Benzinga
3 High-Potential Small-Cap Stocks for Investors With Strong Stomachs
Small-cap stocks can be risky, and all three of these companies are facing adversity. But they could be home run investments. 
Via InvestorPlace
ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery
From ClearPoint Neuro, Inc.
Via GlobeNewswire
3 Healthcare Stocks With Huge Growth Potential
It's been a tough time for the tech industry. So consider these healthcare growth stocks to buy now instead. 
Via InvestorPlace
ClearPoint Neuro's Earnings: A Preview
ClearPoint Neuro (NASDAQ:CLPT) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that ClearPoint... 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.